Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

GU Cancers 2020 | Key RCC data: JAVELIN Renal 101 & CheckMate 214

Pavlos Msaouel, MD, PhD, University of Texas MD Anderson Cancer Center, Houston, TX, gives his opinion on the key kidney cancer data to be taken away from this meeting. Dr Msaouel highlights the JAVELIN Renal 101 (NCT02684006) and CheckMate 214 (NCT02231749) trials, as well as new therapies. This interview took place at the 2020 Genitourinary Cancers Symposium, held in San Francisco, CA.